Cartesian Therapeutics, Inc. Sale of Stock, Price Per Share
Cartesian Therapeutics, Inc. (RNAC) had Sale of Stock, Price Per Share of $1.50 per share as of 2019-01-25, per its 10-Q filed 2019-08-08.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2019-08-08
- 2019-01-25: Sale of Stock, Price Per Share $1.50.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2019-01-25 | $1.50 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |